Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dice Therapeutics (DICE)
NASDAQ:DICE
Holding DICE?
Track your performance easily
DICE Stock Chart & Stats
Day’s Range$47.46 - $47.83
52-Week Range― - ―
Previous Close$47.52
Volume4.33M
Average Volume (3M)N/A
Market Cap
$2.27B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$48.00Price Target Upside0.95% Upside
Rating ConsensusHold
Number of Analyst Covering8
Dice Therapeutics News
PremiumPress Releases
Lilly Completes Acquisition of DICE Therapeutics
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
DICE FAQ
What was Dice Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Dice Therapeutics’s market cap?
Currently, no data Available
When is Dice Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dice Therapeutics’s earnings last quarter?
Currently, no data Available
Is Dice Therapeutics overvalued?
According to Wall Street analysts Dice Therapeutics’s price is currently Undervalued.
Does Dice Therapeutics pay dividends?
Dice Therapeutics does not currently pay dividends.
What is Dice Therapeutics’s EPS estimate?
Dice Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dice Therapeutics have?
Currently, no data Available
What happened to Dice Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dice Therapeutics?
Among the largest hedge funds holding Dice Therapeutics’s share is RA Capital Management. It holds Dice Therapeutics’s shares valued at 225M.
---
Dice Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$48.00 (0.95% Upside)
$48.00 (0.95% Upside)
Blogger Sentiment
Bullish
DICE Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $115.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
Company Description
Dice Therapeutics
DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas.
---
DICE Stock 12 Month Forecast
Average Price Target
$48.00
▲(0.95% Upside)
Best Analysts Covering DICE
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+45.80%
reiterated a buy rating 2 years ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +45.80% per trade.
---